Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Asthma Therapeutics Market Analysis 2016 - Forecast to 2022 - Research and Markets

Research and Markets
Posted on: 27 Sep 16

Research and Markets has announced the addition of the "Global Asthma Therapeutics Market Analysis 2016 - Forecast to 2022" report to their offering.

This report analyzes the global markets for "Asthma Therapeutics". The market assessment is performed through standard and the tailored research methodology approach.

Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porters Five Force Analysis

5 Asthma Therapeutics Market by Route of Administration

  • Parenteral
  • Inhalation
  • Oral

6 Asthma Therapeutics Market by Drug Class

  • Bronchodilators
  • Mast cell stabilizers
  • Anti-inflammatory
  • Immunosuppressants
  • Combination therapies
  • Leukotriene antagonists

7 Asthma Therapeutics Market by Product

  • Nebulizers
  • Inhalers

8 Geographical Segmentation

9 Vendor Landscaping

10 Company Profiles

  • Roche Diagnostics
  • Sanofi-Aventis SA
  • AstraZeneca
  • Merck & Co., Inc.
  • CareFusion Corporation
  • Boehringer Ingelheim
  • Teva Pharmaceutical Industries Ltd.
  • Sunovion Pharmaceuticals, Inc.
  • F. Hoffmann-La Roche
  • Philips Healthcare
  • GSK
  • GlaxoSmithKline Plc
  • Mitsubishi Tanabe Pharma Corporation
  • Pearl Therapeutics
  • Pulmagen Therapeutics
  • Dynavax Technologies Corp.
  • Array BioPharma
  • SAMA Pharmaceuticals
  • Sterna Biologicals
  • Regeneron Pharmaceuticals

For more information about this report visit

View source version on

Business Wire

Last updated on: 27/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.